 |
 |
 |
 |
 |
|
|
|
|
|
Prednisolone acetate 1% was 3.9 times more likely than Lotemax® to cause a clinically significant increase in IOP* although 72% of patients experienced complete resolution of cells and flare with Lotemax after 4 weeks compared to 87% treated with prednisolone acetate (p < 0.02). |
|
|
|
|
 |
|
|
|
In all clinical studies of patients treated for 28 or more days, an IOP elevation of 10 or more mm Hg was reported in only 1.7% of Lotemax patients. |
|
|
|
|
